Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.

Cardnell RJ, Behrens C, Diao L, Fan Y, Tang X, Tong P, Minna JD, Mills GB, Heymach JV, Wistuba II, Wang J, Byers LA.

Clin Cancer Res. 2015 Apr 15. [Epub ahead of print]

PMID:
25878335
2.
3.

The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.

Ao MH, Zhang H, Sakowski L, Sharma R, Illei PB, Gabrielson E, Askin F, Li QK.

Hum Pathol. 2014 May;45(5):926-34. doi: 10.1016/j.humpath.2014.01.005. Epub 2014 Jan 25.

4.

mTOR Inhibition promotes TTF1-dependent redifferentiation and restores iodine uptake in thyroid carcinoma cell lines.

Plantinga TS, Heinhuis B, Gerrits D, Netea MG, Joosten LA, Hermus AR, Oyen WJ, Schweppe RE, Haugen BR, Boerman OC, Smit JW, Netea-Maier RT.

J Clin Endocrinol Metab. 2014 Jul;99(7):E1368-75. doi: 10.1210/jc.2014-1171. Epub 2014 Apr 8.

PMID:
24712572
5.

Evaluation of the microvessel density and the expression of metalloproteases 2 and 9 and ttf1 in the different subtypes of lung adenocarcinoma in Tunisia: a retrospective study of 46 cases.

Mlika M, Makhlouf C, Boudaya MS, Haddouchi C, Tritar F, Mezni F.

J Immunoassay Immunochem. 2015;36(2):111-8. doi: 10.1080/15321819.2014.899258.

PMID:
24689794
6.

Molecular and gene network analysis of thyroid transcription factor 1 (TTF1) and enhanced at puberty (EAP1) genes in patients with GnRH-dependent pubertal disorders.

Cukier P, Wright H, Rulfs T, Silveira LF, Teles MG, Mendonca BB, Arnhold IJ, Heger S, Latronico AC, Ojeda SR, Brito VN.

Horm Res Paediatr. 2013;80(4):257-66. doi: 10.1159/000354643. Epub 2013 Sep 18.

PMID:
24051510
7.

Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes.

Endo T, Kobayashi T.

Endocr Relat Cancer. 2013 Oct 14;20(6):767-76. doi: 10.1530/ERC-13-0310. Print 2013 Dec.

8.

A mutation in TTF1/NKX2.1 is associated with familial neuroendocrine cell hyperplasia of infancy.

Young LR, Deutsch GH, Bokulic RE, Brody AS, Nogee LM.

Chest. 2013 Oct;144(4):1199-206. doi: 10.1378/chest.13-0811.

9.

Role of Napsin A and TTF1 as a diagnostic marker for lung adenocarcinoma.

Iqbal J.

Arch Pathol Lab Med. 2013 Feb;137(2):155. doi: 10.5858/arpa.2012-0123-LE. No abstract available.

PMID:
23368855
10.

Neural lineage-specific homeoprotein BRN2 is directly involved in TTF1 expression in small-cell lung cancer.

Sakaeda M, Sato H, Ishii J, Miyata C, Kamma H, Shishido-Hara Y, Shimoyamada H, Fujiwara M, Endo T, Tanaka R, Kondo H, Goya T, Aoki I, Yazawa T.

Lab Invest. 2013 Apr;93(4):408-21. doi: 10.1038/labinvest.2013.2. Epub 2013 Jan 28.

11.
12.

Inhibition of tumor angiogenesis by TTF1 from extract of herbal medicine.

Liu C, Li XW, Cui LM, Li LC, Chen LY, Zhang XW.

World J Gastroenterol. 2011 Nov 28;17(44):4875-82. doi: 10.3748/wjg.v17.i44.4875.

13.

TTF1-induced apoptosis of HepG-2 cells through a mitochondrial pathway.

Li Y, Bian L, Cui F, Li L, Zhang X.

Oncol Rep. 2011 Sep;26(3):651-7. doi: 10.3892/or.2011.1330. Epub 2011 May 31.

PMID:
21637920
14.

TTF1 expression in normal lung neuroendocrine cells and related tumors: immunohistochemical study comparing two different monoclonal antibodies.

La Rosa S, Chiaravalli AM, Placidi C, Papanikolaou N, Cerati M, Capella C.

Virchows Arch. 2010 Oct;457(4):497-507. doi: 10.1007/s00428-010-0954-0. Epub 2010 Aug 6.

PMID:
20694477
15.

Genetics and phenomics of hypothyroidism and thyroid dys- and agenesis due to PAX8 and TTF1 mutations.

Montanelli L, Tonacchera M.

Mol Cell Endocrinol. 2010 Jun 30;322(1-2):64-71. doi: 10.1016/j.mce.2010.03.009. Epub 2010 Mar 17. Review.

PMID:
20302910
16.

An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.

McCluggage WG, Kennedy K, Busam KJ.

Am J Surg Pathol. 2010 Apr;34(4):525-32. doi: 10.1097/PAS.0b013e3181d1d457.

PMID:
20182342
17.

Five commonly used markers (p53, TTF1, CK7, CK20, and CK34betaE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.

Han CP, Kok LF, Lee MY, Wu TS, Ruan A, Cheng YW, Wang PH, Koo CL, Tyan YS.

Arch Gynecol Obstet. 2010 Feb;281(2):317-23. doi: 10.1007/s00404-009-1115-z. Epub 2009 May 15.

PMID:
19444461
18.

Five new TTF1/NKX2.1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case.

Carré A, Szinnai G, Castanet M, Sura-Trueba S, Tron E, Broutin-L'Hermite I, Barat P, Goizet C, Lacombe D, Moutard ML, Raybaud C, Raynaud-Ravni C, Romana S, Ythier H, Léger J, Polak M.

Hum Mol Genet. 2009 Jun 15;18(12):2266-76. doi: 10.1093/hmg/ddp162. Epub 2009 Mar 31.

19.

TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.

Perner S, Wagner PL, Soltermann A, LaFargue C, Tischler V, Weir BA, Weder W, Meyerson M, Giordano TJ, Moch H, Rubin MA.

J Pathol. 2009 Jan;217(1):65-72. doi: 10.1002/path.2443.

PMID:
18932182
20.

Large cell neuroendocrine carcinoma of the uterine cervix exhibiting TTF1 immunoreactivity.

McCluggage WG, Sargent A, Bailey A, Wilson GE.

Histopathology. 2007 Sep;51(3):405-7. No abstract available.

PMID:
17727482
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk